News Home

Syros Pharmaceuticals Inc (SYRS) Up 4.43% in Premarket Trading

Friday, May 28, 2021 08:30 AM | InvestorsObserver Analysts

Mentioned in this article

Syros Pharmaceuticals Inc (SYRS) Up 4.43% in Premarket Trading

Syros Pharmaceuticals Inc (Syros Pharmaceuticals Inc (SYRS) has gained Friday morning, with the stock climbing 4.43% in pre-market trading to 6.84.

SYRS's short-term technical score of 15 indicates that the stock has traded less bullishly over the last month than 85% of stocks on the market. In the Biotechnology industry, which ranks 143 out of 146 industries, the stock ranks higher than 40% of stocks.

Syros Pharmaceuticals Inc has risen 2.50% over the past month, closing at $6.04 on April 30. During this period of time, the stock fell as low as $5.01 and as high as $7.03. SYRS has an average analyst recommendation of Strong Buy. The company has an average price target of $16.67.

Overall Score - 39
SYRS has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on SYRS!

Syros Pharmaceuticals Inc has a Long-Term Technical rank of 12. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 88% of the market scoring higher. In the Biotechnology industry which is number 140 by this metric, SYRS ranks better than 41% of stocks.

Important Dates for Investors in SYRS:

-Syros Pharmaceuticals Inc is set to release earnings on 8/5/2021. During their last earnings release the company posted EPS of $-1.67. -We do not have a set dividend date for Syros Pharmaceuticals Inc at this time. Click Here to get the full Stock Score Report on Syros Pharmaceuticals Inc (SYRS) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App